RX.V
Price:
$11.2
Market Cap:
$132.13M
BioSyent Inc., a specialty pharmaceutical company, sources, acquires or in-licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX 150, an oral hematinic; FeraMAX Powder, a water soluble oral iron supplement, which helps the body form red blood cells; and FeraMAX Pd Therapeutic 150 for the prevention and treatment of iron deficiency anemia. It also offers Cathejell, a product indicated for surface anesthesia and lubrication during various procedures, including cystoscopy, catheterization, endourethral operation, endoscopy, proctoscopy, rectoscopy, and tracheal intubation, as well as used for the symptomatic treatm...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
1996-05-08
Stock Exchange
TSXV
Ticker
RX.V
According to BioSyent Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 123.95M. This represents a change of 26.82% compared to the average of 97.74M of the last 4 quarters.
The mean historical Enterprise Value of BioSyent Inc. over the last ten years is 100.89M. The current 123.95M Enterprise Value has changed 12.19% with respect to the historical average. Over the past ten years (40 quarters), RX.V's Enterprise Value was at its highest in in the December 2014 quarter at 159.71M. The Enterprise Value was at its lowest in in the March 2020 quarter at 32.72M.
Average
100.89M
Median
96.42M
Minimum
73.48M
Maximum
157.55M
Discovering the peaks and valleys of BioSyent Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 196.26%
Maximum Annual Enterprise Value = 157.55M
Minimum Annual Increase = -41.15%
Minimum Annual Enterprise Value = 73.48M
Year | Enterprise Value | Change |
---|---|---|
2023 | 103.27M | 29.65% |
2022 | 79.65M | -9.83% |
2021 | 88.33M | 4.88% |
2020 | 84.23M | 14.63% |
2019 | 73.48M | -26.62% |
2018 | 100.13M | -21.55% |
2017 | 127.64M | 25.29% |
2016 | 101.87M | 9.88% |
2015 | 92.72M | -41.15% |
2014 | 157.55M | 196.26% |
The current Enterprise Value of BioSyent Inc. (RX.V) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
90.42M
5-year avg
85.79M
10-year avg
100.89M
BioSyent Inc.’s Enterprise Value is less than Cipher Pharmaceuticals Inc. (228.23M), greater than Covalon Technologies Ltd. (84.83M), less than Viemed Healthcare, Inc. (291.11M), less than Hamilton Thorne Ltd. (157.07M), less than Knight Therapeutics Inc. (573.87M),
Company | Enterprise Value | Market cap |
---|---|---|
228.23M | $382.30M | |
84.83M | $93.15M | |
291.11M | $402.21M | |
157.07M | $212.88M | |
573.87M | $576.57M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioSyent Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like BioSyent Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is BioSyent Inc.'s Enterprise Value?
What is the highest Enterprise Value for BioSyent Inc. (RX.V)?
What is the 3-year average Enterprise Value for BioSyent Inc. (RX.V)?
What is the 5-year average Enterprise Value for BioSyent Inc. (RX.V)?
How does the current Enterprise Value for BioSyent Inc. (RX.V) compare to its historical average?